nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—osteoarthritis—Prednisone—psoriasis	0.303	1	CpDpCtD
Ketoprofen—CXCL8—psoriasis	0.29	1	CbGaD
Ketoprofen—ALB—Acitretin—psoriasis	0.0217	0.0762	CbGbCtD
Ketoprofen—CYP2C8—Tazarotene—psoriasis	0.0212	0.0745	CbGbCtD
Ketoprofen—SLCO1A2—Prednisolone—psoriasis	0.0166	0.0584	CbGbCtD
Ketoprofen—PTGS2—Triamcinolone—psoriasis	0.0161	0.0565	CbGbCtD
Ketoprofen—SLCO1A2—Hydrocortisone—psoriasis	0.0157	0.0554	CbGbCtD
Ketoprofen—SLCO1A2—Prednisone—psoriasis	0.0157	0.0552	CbGbCtD
Ketoprofen—SLCO1A2—Cyclosporine—psoriasis	0.0149	0.0523	CbGbCtD
Ketoprofen—PTGS2—Betamethasone—psoriasis	0.0138	0.0485	CbGbCtD
Ketoprofen—SLC22A11—Methotrexate—psoriasis	0.0118	0.0414	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—psoriasis	0.0112	0.0395	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—psoriasis	0.011	0.0386	CbGbCtD
Ketoprofen—ALB—Mycophenolate mofetil—psoriasis	0.0101	0.0357	CbGbCtD
Ketoprofen—SLCO1A2—Dexamethasone—psoriasis	0.00979	0.0344	CbGbCtD
Ketoprofen—CYP2C8—Cholecalciferol—psoriasis	0.00904	0.0318	CbGbCtD
Ketoprofen—SLC22A6—Cyclosporine—psoriasis	0.00902	0.0317	CbGbCtD
Ketoprofen—ALB—Prednisone—psoriasis	0.00811	0.0285	CbGbCtD
Ketoprofen—PTGS2—Dexamethasone—psoriasis	0.00802	0.0282	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—psoriasis	0.00787	0.0277	CbGbCtD
Ketoprofen—CYP2C8—Mycophenolate mofetil—psoriasis	0.00784	0.0276	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—psoriasis	0.00685	0.0241	CbGbCtD
Ketoprofen—CYP2C9—Cholecalciferol—psoriasis	0.0063	0.0222	CbGbCtD
Ketoprofen—CYP2C8—Hydrocortisone—psoriasis	0.00629	0.0221	CbGbCtD
Ketoprofen—CYP2C8—Cyclosporine—psoriasis	0.00594	0.0209	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—psoriasis	0.00477	0.0168	CbGbCtD
Ketoprofen—CYP2C9—Cyclosporine—psoriasis	0.00414	0.0146	CbGbCtD
Ketoprofen—ALB—Methotrexate—psoriasis	0.00407	0.0143	CbGbCtD
Ketoprofen—CYP2C8—Dexamethasone—psoriasis	0.00391	0.0138	CbGbCtD
Ketoprofen—CYP2C9—Dexamethasone—psoriasis	0.00273	0.00959	CbGbCtD
Ketoprofen—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000318	0.157	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000255	0.126	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000248	0.122	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000192	0.0949	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000154	0.076	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000154	0.076	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000149	0.0738	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000116	0.0574	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000116	0.0574	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000114	0.0561	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	7.01e-05	0.0346	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	7.01e-05	0.0346	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	6.85e-05	0.0338	CbGdCrCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	6.55e-05	0.00207	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	6.46e-05	0.00204	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—JUN—psoriasis	6.42e-05	0.00203	CbGpPWpGaD
Ketoprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	6.42e-05	0.00203	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	6.35e-05	0.00201	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.3e-05	0.00199	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	6.18e-05	0.00196	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	6.18e-05	0.00195	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IFNG—psoriasis	6.1e-05	0.00193	CbGpPWpGaD
Ketoprofen—CXCL8—TSLP Signaling Pathway—IL6—psoriasis	6.06e-05	0.00192	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	5.89e-05	0.00186	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—VEGFA—psoriasis	5.78e-05	0.00183	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CAT—psoriasis	5.64e-05	0.00178	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—NFKB1—psoriasis	5.64e-05	0.00178	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	5.56e-05	0.00176	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IFNG—psoriasis	5.55e-05	0.00176	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	5.54e-05	0.00175	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	5.54e-05	0.00175	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—CRP—psoriasis	5.51e-05	0.00174	CbGpPWpGaD
Ketoprofen—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	5.48e-05	0.00173	CbGpPWpGaD
Ketoprofen—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	5.47e-05	0.00173	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—JUN—psoriasis	5.39e-05	0.00171	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—APOE—psoriasis	5.39e-05	0.0017	CbGpPWpGaD
Ketoprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.31e-05	0.00168	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—JUN—psoriasis	5.27e-05	0.00167	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—JUN—psoriasis	5.27e-05	0.00167	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CAT—psoriasis	5.25e-05	0.00166	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	5.24e-05	0.00166	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	5.19e-05	0.00164	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL4—psoriasis	5.18e-05	0.00164	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	5.09e-05	0.00161	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—psoriasis	5.07e-05	0.0016	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	5.06e-05	0.0016	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—IL6—psoriasis	5.05e-05	0.0016	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TNF—psoriasis	4.96e-05	0.00157	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	4.93e-05	0.00156	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—REN—psoriasis	4.92e-05	0.00156	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	4.84e-05	0.00153	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—psoriasis	4.81e-05	0.00152	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	4.7e-05	0.00149	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	4.57e-05	0.000512	CcSEcCtD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—STAT3—psoriasis	4.56e-05	0.00144	CbGpPWpGaD
Ketoprofen—Malaise—Dexamethasone—psoriasis	4.55e-05	0.00051	CcSEcCtD
Ketoprofen—Malaise—Betamethasone—psoriasis	4.55e-05	0.00051	CcSEcCtD
Ketoprofen—Anaphylactic shock—Triamcinolone—psoriasis	4.54e-05	0.000508	CcSEcCtD
Ketoprofen—Oedema—Triamcinolone—psoriasis	4.54e-05	0.000508	CcSEcCtD
Ketoprofen—Vertigo—Dexamethasone—psoriasis	4.54e-05	0.000508	CcSEcCtD
Ketoprofen—Vertigo—Betamethasone—psoriasis	4.54e-05	0.000508	CcSEcCtD
Ketoprofen—Constipation—Mycophenolate mofetil—psoriasis	4.53e-05	0.000507	CcSEcCtD
Ketoprofen—Arrhythmia—Prednisone—psoriasis	4.51e-05	0.000505	CcSEcCtD
Ketoprofen—Infection—Triamcinolone—psoriasis	4.51e-05	0.000505	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—psoriasis	4.51e-05	0.000505	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	4.5e-05	0.00142	CbGpPWpGaD
Ketoprofen—Haematuria—Methotrexate—psoriasis	4.48e-05	0.000502	CcSEcCtD
Ketoprofen—ABCC4—Platelet degranulation—VEGFA—psoriasis	4.48e-05	0.00142	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL20—psoriasis	4.48e-05	0.00142	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—CAT—psoriasis	4.48e-05	0.00142	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CRP—psoriasis	4.48e-05	0.00142	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	4.48e-05	0.00141	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Cyclosporine—psoriasis	4.47e-05	0.000501	CcSEcCtD
Ketoprofen—Shock—Triamcinolone—psoriasis	4.47e-05	0.0005	CcSEcCtD
Ketoprofen—Insomnia—Prednisolone—psoriasis	4.47e-05	0.0005	CcSEcCtD
Ketoprofen—Alopecia—Prednisone—psoriasis	4.46e-05	0.0005	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Cyclosporine—psoriasis	4.44e-05	0.000497	CcSEcCtD
Ketoprofen—Dizziness—Mycophenolic acid—psoriasis	4.44e-05	0.000497	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—psoriasis	4.44e-05	0.000496	CcSEcCtD
Ketoprofen—Paraesthesia—Prednisolone—psoriasis	4.43e-05	0.000496	CcSEcCtD
Ketoprofen—Tachycardia—Triamcinolone—psoriasis	4.43e-05	0.000496	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL6—psoriasis	4.41e-05	0.00139	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	4.4e-05	0.00139	CbGpPWpGaD
Ketoprofen—Erythema—Prednisone—psoriasis	4.4e-05	0.000492	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Hydrocortisone—psoriasis	4.39e-05	0.000492	CcSEcCtD
Ketoprofen—Hyperhidrosis—Triamcinolone—psoriasis	4.39e-05	0.000491	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—psoriasis	4.39e-05	0.000491	CcSEcCtD
Ketoprofen—Convulsion—Dexamethasone—psoriasis	4.37e-05	0.00049	CcSEcCtD
Ketoprofen—Convulsion—Betamethasone—psoriasis	4.37e-05	0.00049	CcSEcCtD
Ketoprofen—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.36e-05	0.000488	CcSEcCtD
Ketoprofen—Insomnia—Hydrocortisone—psoriasis	4.36e-05	0.000488	CcSEcCtD
Ketoprofen—Hypertension—Betamethasone—psoriasis	4.36e-05	0.000488	CcSEcCtD
Ketoprofen—Hypertension—Dexamethasone—psoriasis	4.36e-05	0.000488	CcSEcCtD
Ketoprofen—Paraesthesia—Hydrocortisone—psoriasis	4.33e-05	0.000485	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.33e-05	0.000485	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—ITGAL—psoriasis	4.31e-05	0.00136	CbGpPWpGaD
Ketoprofen—Urticaria—Cyclosporine—psoriasis	4.31e-05	0.000483	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.3e-05	0.00136	CbGpPWpGaD
Ketoprofen—Myalgia—Dexamethasone—psoriasis	4.3e-05	0.000481	CcSEcCtD
Ketoprofen—Myalgia—Betamethasone—psoriasis	4.3e-05	0.000481	CcSEcCtD
Ketoprofen—Abdominal pain—Cyclosporine—psoriasis	4.29e-05	0.00048	CcSEcCtD
Ketoprofen—Anxiety—Dexamethasone—psoriasis	4.28e-05	0.00048	CcSEcCtD
Ketoprofen—Anxiety—Betamethasone—psoriasis	4.28e-05	0.00048	CcSEcCtD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	4.27e-05	0.00135	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	4.27e-05	0.00135	CbGpPWpGaD
Ketoprofen—Vomiting—Mycophenolic acid—psoriasis	4.27e-05	0.000477	CcSEcCtD
Ketoprofen—Discomfort—Dexamethasone—psoriasis	4.25e-05	0.000475	CcSEcCtD
Ketoprofen—Discomfort—Betamethasone—psoriasis	4.25e-05	0.000475	CcSEcCtD
Ketoprofen—Dyspepsia—Hydrocortisone—psoriasis	4.25e-05	0.000475	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—psoriasis	4.24e-05	0.00134	CbGpPWpGaD
Ketoprofen—Rash—Mycophenolic acid—psoriasis	4.23e-05	0.000473	CcSEcCtD
Ketoprofen—Dermatitis—Mycophenolic acid—psoriasis	4.23e-05	0.000473	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—psoriasis	4.22e-05	0.000473	CcSEcCtD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	4.21e-05	0.00133	CbGpPWpGaD
Ketoprofen—Urticaria—Mycophenolate mofetil—psoriasis	4.21e-05	0.000471	CcSEcCtD
Ketoprofen—Headache—Mycophenolic acid—psoriasis	4.2e-05	0.00047	CcSEcCtD
Ketoprofen—Decreased appetite—Hydrocortisone—psoriasis	4.19e-05	0.000469	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—psoriasis	4.19e-05	0.000469	CcSEcCtD
Ketoprofen—Abdominal pain—Mycophenolate mofetil—psoriasis	4.19e-05	0.000468	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	4.18e-05	0.00132	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.16e-05	0.000466	CcSEcCtD
Ketoprofen—Fatigue—Hydrocortisone—psoriasis	4.16e-05	0.000465	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.14e-05	0.000463	CcSEcCtD
Ketoprofen—Anaphylactic shock—Betamethasone—psoriasis	4.12e-05	0.000461	CcSEcCtD
Ketoprofen—Anaphylactic shock—Dexamethasone—psoriasis	4.12e-05	0.000461	CcSEcCtD
Ketoprofen—Oedema—Dexamethasone—psoriasis	4.12e-05	0.000461	CcSEcCtD
Ketoprofen—Oedema—Betamethasone—psoriasis	4.12e-05	0.000461	CcSEcCtD
Ketoprofen—ALB—Folate Metabolism—ICAM1—psoriasis	4.12e-05	0.0013	CbGpPWpGaD
Ketoprofen—Insomnia—Triamcinolone—psoriasis	4.11e-05	0.00046	CcSEcCtD
Ketoprofen—Infection—Betamethasone—psoriasis	4.09e-05	0.000458	CcSEcCtD
Ketoprofen—Infection—Dexamethasone—psoriasis	4.09e-05	0.000458	CcSEcCtD
Ketoprofen—Ill-defined disorder—Prednisone—psoriasis	4.08e-05	0.000457	CcSEcCtD
Ketoprofen—Paraesthesia—Triamcinolone—psoriasis	4.08e-05	0.000456	CcSEcCtD
Ketoprofen—Feeling abnormal—Prednisolone—psoriasis	4.07e-05	0.000456	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—psoriasis	4.07e-05	0.000455	CcSEcCtD
Ketoprofen—Anaemia—Prednisone—psoriasis	4.06e-05	0.000455	CcSEcCtD
Ketoprofen—Shock—Betamethasone—psoriasis	4.05e-05	0.000454	CcSEcCtD
Ketoprofen—Shock—Dexamethasone—psoriasis	4.05e-05	0.000454	CcSEcCtD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	4.05e-05	0.00128	CbGpPWpGaD
Ketoprofen—Dyspnoea—Triamcinolone—psoriasis	4.05e-05	0.000453	CcSEcCtD
Ketoprofen—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	4.04e-05	0.00128	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—psoriasis	4.04e-05	0.00128	CbGpPWpGaD
Ketoprofen—Thrombocytopenia—Dexamethasone—psoriasis	4.03e-05	0.000452	CcSEcCtD
Ketoprofen—Thrombocytopenia—Betamethasone—psoriasis	4.03e-05	0.000452	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—IL4—psoriasis	4.03e-05	0.00127	CbGpPWpGaD
Ketoprofen—Tachycardia—Dexamethasone—psoriasis	4.02e-05	0.00045	CcSEcCtD
Ketoprofen—Tachycardia—Betamethasone—psoriasis	4.02e-05	0.00045	CcSEcCtD
Ketoprofen—Angioedema—Prednisone—psoriasis	4.02e-05	0.00045	CcSEcCtD
Ketoprofen—Hypersensitivity—Cyclosporine—psoriasis	4e-05	0.000448	CcSEcCtD
Ketoprofen—Dyspepsia—Triamcinolone—psoriasis	4e-05	0.000447	CcSEcCtD
Ketoprofen—CXCR1—GPCR ligand binding—CXCL8—psoriasis	3.99e-05	0.00126	CbGpPWpGaD
Ketoprofen—Erythema multiforme—Methotrexate—psoriasis	3.99e-05	0.000447	CcSEcCtD
Ketoprofen—Nausea—Mycophenolic acid—psoriasis	3.99e-05	0.000446	CcSEcCtD
Ketoprofen—Hyperhidrosis—Dexamethasone—psoriasis	3.98e-05	0.000446	CcSEcCtD
Ketoprofen—Hyperhidrosis—Betamethasone—psoriasis	3.98e-05	0.000446	CcSEcCtD
Ketoprofen—Feeling abnormal—Hydrocortisone—psoriasis	3.97e-05	0.000445	CcSEcCtD
Ketoprofen—Malaise—Prednisone—psoriasis	3.97e-05	0.000444	CcSEcCtD
Ketoprofen—Vertigo—Prednisone—psoriasis	3.95e-05	0.000442	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Hydrocortisone—psoriasis	3.94e-05	0.000441	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—psoriasis	3.94e-05	0.000441	CcSEcCtD
Ketoprofen—Anorexia—Betamethasone—psoriasis	3.93e-05	0.00044	CcSEcCtD
Ketoprofen—Anorexia—Dexamethasone—psoriasis	3.93e-05	0.00044	CcSEcCtD
Ketoprofen—Urticaria—Prednisolone—psoriasis	3.92e-05	0.000439	CcSEcCtD
Ketoprofen—Fatigue—Triamcinolone—psoriasis	3.92e-05	0.000438	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.9e-05	0.00123	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.9e-05	0.000437	CcSEcCtD
Ketoprofen—CXCL8—Signaling Pathways—HCAR2—psoriasis	3.89e-05	0.00123	CbGpPWpGaD
Ketoprofen—Asthenia—Cyclosporine—psoriasis	3.89e-05	0.000436	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL6—psoriasis	3.88e-05	0.00123	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	3.88e-05	0.00123	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	3.85e-05	0.00122	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—JUN—psoriasis	3.84e-05	0.00121	CbGpPWpGaD
Ketoprofen—Pruritus—Cyclosporine—psoriasis	3.84e-05	0.00043	CcSEcCtD
Ketoprofen—Urticaria—Hydrocortisone—psoriasis	3.83e-05	0.000429	CcSEcCtD
Ketoprofen—Abdominal pain—Hydrocortisone—psoriasis	3.81e-05	0.000427	CcSEcCtD
Ketoprofen—Convulsion—Prednisone—psoriasis	3.81e-05	0.000426	CcSEcCtD
Ketoprofen—Asthenia—Mycophenolate mofetil—psoriasis	3.8e-05	0.000425	CcSEcCtD
Ketoprofen—Hypertension—Prednisone—psoriasis	3.8e-05	0.000425	CcSEcCtD
Ketoprofen—Chills—Methotrexate—psoriasis	3.79e-05	0.000424	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—CCL20—psoriasis	3.77e-05	0.00119	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	3.76e-05	0.00119	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.75e-05	0.00042	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Betamethasone—psoriasis	3.75e-05	0.00042	CcSEcCtD
Ketoprofen—Pruritus—Mycophenolate mofetil—psoriasis	3.75e-05	0.000419	CcSEcCtD
Ketoprofen—Myalgia—Prednisone—psoriasis	3.74e-05	0.000419	CcSEcCtD
Ketoprofen—Feeling abnormal—Triamcinolone—psoriasis	3.74e-05	0.000419	CcSEcCtD
Ketoprofen—Anxiety—Prednisone—psoriasis	3.73e-05	0.000418	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—psoriasis	3.73e-05	0.000418	CcSEcCtD
Ketoprofen—Insomnia—Betamethasone—psoriasis	3.73e-05	0.000417	CcSEcCtD
Ketoprofen—Insomnia—Dexamethasone—psoriasis	3.73e-05	0.000417	CcSEcCtD
Ketoprofen—Diarrhoea—Cyclosporine—psoriasis	3.71e-05	0.000416	CcSEcCtD
Ketoprofen—Paraesthesia—Betamethasone—psoriasis	3.7e-05	0.000414	CcSEcCtD
Ketoprofen—Paraesthesia—Dexamethasone—psoriasis	3.7e-05	0.000414	CcSEcCtD
Ketoprofen—Discomfort—Prednisone—psoriasis	3.7e-05	0.000414	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.7e-05	0.00117	CbGpPWpGaD
Ketoprofen—Erythema—Methotrexate—psoriasis	3.68e-05	0.000411	CcSEcCtD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	3.67e-05	0.00116	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Prednisolone—psoriasis	3.64e-05	0.000407	CcSEcCtD
Ketoprofen—Dyspepsia—Dexamethasone—psoriasis	3.63e-05	0.000406	CcSEcCtD
Ketoprofen—Dyspepsia—Betamethasone—psoriasis	3.63e-05	0.000406	CcSEcCtD
Ketoprofen—Diarrhoea—Mycophenolate mofetil—psoriasis	3.62e-05	0.000405	CcSEcCtD
Ketoprofen—Urticaria—Triamcinolone—psoriasis	3.61e-05	0.000404	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	3.61e-05	0.00114	CbGpPWpGaD
Ketoprofen—Dysgeusia—Methotrexate—psoriasis	3.6e-05	0.000403	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—TNF—psoriasis	3.59e-05	0.00114	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NDUFA5—psoriasis	3.59e-05	0.00114	CbGpPWpGaD
Ketoprofen—Dizziness—Cyclosporine—psoriasis	3.59e-05	0.000402	CcSEcCtD
Ketoprofen—Anaphylactic shock—Prednisone—psoriasis	3.59e-05	0.000402	CcSEcCtD
Ketoprofen—Oedema—Prednisone—psoriasis	3.59e-05	0.000402	CcSEcCtD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	3.59e-05	0.00113	CbGpPWpGaD
Ketoprofen—Decreased appetite—Betamethasone—psoriasis	3.58e-05	0.000401	CcSEcCtD
Ketoprofen—Decreased appetite—Dexamethasone—psoriasis	3.58e-05	0.000401	CcSEcCtD
Ketoprofen—Infection—Prednisone—psoriasis	3.57e-05	0.000399	CcSEcCtD
Ketoprofen—ALB—Selenium Micronutrient Network—CRP—psoriasis	3.56e-05	0.00113	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Dexamethasone—psoriasis	3.56e-05	0.000398	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Betamethasone—psoriasis	3.56e-05	0.000398	CcSEcCtD
Ketoprofen—Hypersensitivity—Hydrocortisone—psoriasis	3.55e-05	0.000398	CcSEcCtD
Ketoprofen—Fatigue—Dexamethasone—psoriasis	3.55e-05	0.000398	CcSEcCtD
Ketoprofen—Fatigue—Betamethasone—psoriasis	3.55e-05	0.000398	CcSEcCtD
Ketoprofen—Shock—Prednisone—psoriasis	3.53e-05	0.000395	CcSEcCtD
Ketoprofen—Tachycardia—Prednisone—psoriasis	3.5e-05	0.000392	CcSEcCtD
Ketoprofen—Dizziness—Mycophenolate mofetil—psoriasis	3.5e-05	0.000392	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—psoriasis	3.48e-05	0.0011	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Prednisone—psoriasis	3.47e-05	0.000388	CcSEcCtD
Ketoprofen—Asthenia—Hydrocortisone—psoriasis	3.46e-05	0.000387	CcSEcCtD
Ketoprofen—Vomiting—Cyclosporine—psoriasis	3.45e-05	0.000386	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	3.44e-05	0.00109	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL20—psoriasis	3.42e-05	0.00108	CbGpPWpGaD
Ketoprofen—Rash—Cyclosporine—psoriasis	3.42e-05	0.000383	CcSEcCtD
Ketoprofen—Anorexia—Prednisone—psoriasis	3.42e-05	0.000383	CcSEcCtD
Ketoprofen—Dermatitis—Cyclosporine—psoriasis	3.42e-05	0.000383	CcSEcCtD
Ketoprofen—Pruritus—Hydrocortisone—psoriasis	3.41e-05	0.000382	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—psoriasis	3.41e-05	0.000382	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—LEP—psoriasis	3.4e-05	0.00108	CbGpPWpGaD
Ketoprofen—Headache—Cyclosporine—psoriasis	3.4e-05	0.000381	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—psoriasis	3.4e-05	0.00038	CcSEcCtD
Ketoprofen—Feeling abnormal—Dexamethasone—psoriasis	3.4e-05	0.00038	CcSEcCtD
Ketoprofen—Feeling abnormal—Betamethasone—psoriasis	3.4e-05	0.00038	CcSEcCtD
Ketoprofen—CXCL8—Signaling Pathways—TAGAP—psoriasis	3.38e-05	0.00107	CbGpPWpGaD
Ketoprofen—Gastrointestinal pain—Dexamethasone—psoriasis	3.37e-05	0.000377	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Betamethasone—psoriasis	3.37e-05	0.000377	CcSEcCtD
Ketoprofen—Vomiting—Mycophenolate mofetil—psoriasis	3.37e-05	0.000377	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.36e-05	0.00106	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.35e-05	0.00106	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Triamcinolone—psoriasis	3.35e-05	0.000375	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.35e-05	0.00106	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	3.34e-05	0.00106	CbGpPWpGaD
Ketoprofen—Rash—Mycophenolate mofetil—psoriasis	3.34e-05	0.000374	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—JUN—psoriasis	3.34e-05	0.00105	CbGpPWpGaD
Ketoprofen—Dermatitis—Mycophenolate mofetil—psoriasis	3.34e-05	0.000373	CcSEcCtD
Ketoprofen—Headache—Mycophenolate mofetil—psoriasis	3.32e-05	0.000371	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—psoriasis	3.31e-05	0.000371	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—psoriasis	3.3e-05	0.00037	CcSEcCtD
Ketoprofen—Diarrhoea—Hydrocortisone—psoriasis	3.3e-05	0.000369	CcSEcCtD
Ketoprofen—Urticaria—Dexamethasone—psoriasis	3.27e-05	0.000366	CcSEcCtD
Ketoprofen—Urticaria—Betamethasone—psoriasis	3.27e-05	0.000366	CcSEcCtD
Ketoprofen—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.27e-05	0.00103	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Prednisone—psoriasis	3.27e-05	0.000366	CcSEcCtD
Ketoprofen—Dizziness—Prednisolone—psoriasis	3.27e-05	0.000366	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL6—psoriasis	3.26e-05	0.00103	CbGpPWpGaD
Ketoprofen—Asthenia—Triamcinolone—psoriasis	3.26e-05	0.000365	CcSEcCtD
Ketoprofen—Abdominal pain—Betamethasone—psoriasis	3.26e-05	0.000365	CcSEcCtD
Ketoprofen—Abdominal pain—Dexamethasone—psoriasis	3.26e-05	0.000365	CcSEcCtD
Ketoprofen—Insomnia—Prednisone—psoriasis	3.25e-05	0.000363	CcSEcCtD
Ketoprofen—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	3.22e-05	0.00102	CbGpPWpGaD
Ketoprofen—Nausea—Cyclosporine—psoriasis	3.22e-05	0.000361	CcSEcCtD
Ketoprofen—Paraesthesia—Prednisone—psoriasis	3.22e-05	0.000361	CcSEcCtD
Ketoprofen—Pruritus—Triamcinolone—psoriasis	3.21e-05	0.00036	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—NFKB1—psoriasis	3.21e-05	0.00102	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—CP—psoriasis	3.21e-05	0.00102	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	3.2e-05	0.00101	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	3.2e-05	0.00101	CbGpPWpGaD
Ketoprofen—Dizziness—Hydrocortisone—psoriasis	3.19e-05	0.000357	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.19e-05	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL6—psoriasis	3.19e-05	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—psoriasis	3.19e-05	0.00101	CbGpPWpGaD
Ketoprofen—Convulsion—Methotrexate—psoriasis	3.18e-05	0.000356	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—NOS2—psoriasis	3.17e-05	0.001	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—psoriasis	3.17e-05	0.001	CbGpPWpGaD
Ketoprofen—Dyspepsia—Prednisone—psoriasis	3.16e-05	0.000354	CcSEcCtD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	3.15e-05	0.000997	CbGpPWpGaD
Ketoprofen—Nausea—Mycophenolate mofetil—psoriasis	3.14e-05	0.000352	CcSEcCtD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	3.14e-05	0.000992	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IFNG—psoriasis	3.13e-05	0.000991	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	3.13e-05	0.00099	CbGpPWpGaD
Ketoprofen—Myalgia—Methotrexate—psoriasis	3.13e-05	0.00035	CcSEcCtD
Ketoprofen—Decreased appetite—Prednisone—psoriasis	3.12e-05	0.000349	CcSEcCtD
Ketoprofen—Rash—Prednisolone—psoriasis	3.11e-05	0.000349	CcSEcCtD
Ketoprofen—Dermatitis—Prednisolone—psoriasis	3.11e-05	0.000348	CcSEcCtD
Ketoprofen—Fatigue—Prednisone—psoriasis	3.09e-05	0.000346	CcSEcCtD
Ketoprofen—Headache—Prednisolone—psoriasis	3.09e-05	0.000346	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—psoriasis	3.09e-05	0.000346	CcSEcCtD
Ketoprofen—PTGS2—C-MYB transcription factor network—CD4—psoriasis	3.08e-05	0.000975	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	3.08e-05	0.000973	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—ACE—psoriasis	3.07e-05	0.000971	CbGpPWpGaD
Ketoprofen—Constipation—Prednisone—psoriasis	3.07e-05	0.000344	CcSEcCtD
Ketoprofen—Vomiting—Hydrocortisone—psoriasis	3.07e-05	0.000343	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.06e-05	0.000966	CbGpPWpGaD
Ketoprofen—Rash—Hydrocortisone—psoriasis	3.04e-05	0.00034	CcSEcCtD
Ketoprofen—Dermatitis—Hydrocortisone—psoriasis	3.04e-05	0.00034	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—psoriasis	3.02e-05	0.000338	CcSEcCtD
Ketoprofen—Headache—Hydrocortisone—psoriasis	3.02e-05	0.000338	CcSEcCtD
Ketoprofen—Dizziness—Triamcinolone—psoriasis	3e-05	0.000336	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—psoriasis	3e-05	0.000336	CcSEcCtD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	2.99e-05	0.000947	CbGpPWpGaD
Ketoprofen—Infection—Methotrexate—psoriasis	2.98e-05	0.000334	CcSEcCtD
Ketoprofen—Feeling abnormal—Prednisone—psoriasis	2.96e-05	0.000331	CcSEcCtD
Ketoprofen—Asthenia—Dexamethasone—psoriasis	2.96e-05	0.000331	CcSEcCtD
Ketoprofen—Asthenia—Betamethasone—psoriasis	2.96e-05	0.000331	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—psoriasis	2.94e-05	0.000329	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Prednisone—psoriasis	2.93e-05	0.000328	CcSEcCtD
Ketoprofen—Nausea—Prednisolone—psoriasis	2.93e-05	0.000328	CcSEcCtD
Ketoprofen—Pruritus—Betamethasone—psoriasis	2.92e-05	0.000326	CcSEcCtD
Ketoprofen—Pruritus—Dexamethasone—psoriasis	2.92e-05	0.000326	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—IL6—psoriasis	2.9e-05	0.000917	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Methotrexate—psoriasis	2.9e-05	0.000325	CcSEcCtD
Ketoprofen—Vomiting—Triamcinolone—psoriasis	2.89e-05	0.000323	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—STAT3—psoriasis	2.89e-05	0.000912	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—TNF—psoriasis	2.88e-05	0.000909	CbGpPWpGaD
Ketoprofen—Nausea—Hydrocortisone—psoriasis	2.87e-05	0.000321	CcSEcCtD
Ketoprofen—Rash—Triamcinolone—psoriasis	2.86e-05	0.000321	CcSEcCtD
Ketoprofen—Dermatitis—Triamcinolone—psoriasis	2.86e-05	0.00032	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—psoriasis	2.86e-05	0.00032	CcSEcCtD
Ketoprofen—Urticaria—Prednisone—psoriasis	2.85e-05	0.000319	CcSEcCtD
Ketoprofen—Headache—Triamcinolone—psoriasis	2.85e-05	0.000318	CcSEcCtD
Ketoprofen—Abdominal pain—Prednisone—psoriasis	2.84e-05	0.000318	CcSEcCtD
Ketoprofen—Diarrhoea—Dexamethasone—psoriasis	2.82e-05	0.000316	CcSEcCtD
Ketoprofen—Diarrhoea—Betamethasone—psoriasis	2.82e-05	0.000316	CcSEcCtD
Ketoprofen—PTGS1—Metabolism—NDUFA5—psoriasis	2.73e-05	0.000864	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—psoriasis	2.73e-05	0.000306	CcSEcCtD
Ketoprofen—Dizziness—Dexamethasone—psoriasis	2.73e-05	0.000305	CcSEcCtD
Ketoprofen—Dizziness—Betamethasone—psoriasis	2.73e-05	0.000305	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—psoriasis	2.71e-05	0.000304	CcSEcCtD
Ketoprofen—Nausea—Triamcinolone—psoriasis	2.7e-05	0.000302	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—psoriasis	2.69e-05	0.000301	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—psoriasis	2.67e-05	0.000299	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—psoriasis	2.67e-05	0.000298	CcSEcCtD
Ketoprofen—Hypersensitivity—Prednisone—psoriasis	2.64e-05	0.000296	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—psoriasis	2.64e-05	0.000296	CcSEcCtD
Ketoprofen—Vomiting—Betamethasone—psoriasis	2.62e-05	0.000293	CcSEcCtD
Ketoprofen—Vomiting—Dexamethasone—psoriasis	2.62e-05	0.000293	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—psoriasis	2.61e-05	0.000292	CcSEcCtD
Ketoprofen—ALB—Folate Metabolism—NFKB1—psoriasis	2.61e-05	0.000824	CbGpPWpGaD
Ketoprofen—Rash—Dexamethasone—psoriasis	2.6e-05	0.000291	CcSEcCtD
Ketoprofen—Rash—Betamethasone—psoriasis	2.6e-05	0.000291	CcSEcCtD
Ketoprofen—Dermatitis—Betamethasone—psoriasis	2.6e-05	0.000291	CcSEcCtD
Ketoprofen—Dermatitis—Dexamethasone—psoriasis	2.6e-05	0.000291	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—psoriasis	2.59e-05	0.00029	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—psoriasis	2.59e-05	0.000289	CcSEcCtD
Ketoprofen—Headache—Dexamethasone—psoriasis	2.58e-05	0.000289	CcSEcCtD
Ketoprofen—Headache—Betamethasone—psoriasis	2.58e-05	0.000289	CcSEcCtD
Ketoprofen—Asthenia—Prednisone—psoriasis	2.57e-05	0.000288	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.57e-05	0.000812	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	2.56e-05	0.000809	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.55e-05	0.000806	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	2.54e-05	0.000805	CbGpPWpGaD
Ketoprofen—Pruritus—Prednisone—psoriasis	2.54e-05	0.000284	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—JUN—psoriasis	2.52e-05	0.000797	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	2.51e-05	0.000793	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—TNF—psoriasis	2.49e-05	0.000788	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IFNG—psoriasis	2.49e-05	0.000787	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Methotrexate—psoriasis	2.47e-05	0.000277	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—SOCS1—psoriasis	2.47e-05	0.00078	CbGpPWpGaD
Ketoprofen—Diarrhoea—Prednisone—psoriasis	2.46e-05	0.000275	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—psoriasis	2.45e-05	0.000275	CcSEcCtD
Ketoprofen—Nausea—Betamethasone—psoriasis	2.45e-05	0.000274	CcSEcCtD
Ketoprofen—Nausea—Dexamethasone—psoriasis	2.45e-05	0.000274	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—IFNG—psoriasis	2.43e-05	0.000769	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—NFKB1—psoriasis	2.43e-05	0.000767	CbGpPWpGaD
Ketoprofen—Urticaria—Methotrexate—psoriasis	2.38e-05	0.000267	CcSEcCtD
Ketoprofen—Dizziness—Prednisone—psoriasis	2.37e-05	0.000266	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—psoriasis	2.37e-05	0.000265	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—TYK2—psoriasis	2.35e-05	0.000744	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP2S1—psoriasis	2.32e-05	0.000735	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL6—psoriasis	2.32e-05	0.000734	CbGpPWpGaD
Ketoprofen—Vomiting—Prednisone—psoriasis	2.28e-05	0.000255	CcSEcCtD
Ketoprofen—Rash—Prednisone—psoriasis	2.26e-05	0.000253	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	2.26e-05	0.000715	CbGpPWpGaD
Ketoprofen—Dermatitis—Prednisone—psoriasis	2.26e-05	0.000253	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—CXCL8—psoriasis	2.26e-05	0.000713	CbGpPWpGaD
Ketoprofen—Headache—Prednisone—psoriasis	2.25e-05	0.000252	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—psoriasis	2.21e-05	0.000247	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—VEGFA—psoriasis	2.2e-05	0.000696	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—psoriasis	2.2e-05	0.000696	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—STAT3—psoriasis	2.18e-05	0.000689	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NDUFA5—psoriasis	2.17e-05	0.000686	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.16e-05	0.000682	CbGpPWpGaD
Ketoprofen—Asthenia—Methotrexate—psoriasis	2.15e-05	0.000241	CcSEcCtD
Ketoprofen—Nausea—Prednisone—psoriasis	2.13e-05	0.000239	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—psoriasis	2.12e-05	0.000238	CcSEcCtD
Ketoprofen—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.07e-05	0.000655	CbGpPWpGaD
Ketoprofen—Diarrhoea—Methotrexate—psoriasis	2.05e-05	0.00023	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CXCL8—psoriasis	2.05e-05	0.000648	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—VEGFA—psoriasis	2.03e-05	0.000641	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TNF—psoriasis	2.03e-05	0.000641	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	2.02e-05	0.00064	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.02e-05	0.00064	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL20—psoriasis	2.02e-05	0.00064	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—IL6—psoriasis	2.02e-05	0.000637	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.01e-05	0.000636	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.99e-05	0.00063	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.99e-05	0.000629	CbGpPWpGaD
Ketoprofen—Dizziness—Methotrexate—psoriasis	1.98e-05	0.000222	CcSEcCtD
Ketoprofen—ALB—Hemostasis—ITGAL—psoriasis	1.95e-05	0.000617	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.93e-05	0.000611	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—LEP—psoriasis	1.91e-05	0.000603	CbGpPWpGaD
Ketoprofen—Vomiting—Methotrexate—psoriasis	1.91e-05	0.000213	CcSEcCtD
Ketoprofen—Rash—Methotrexate—psoriasis	1.89e-05	0.000212	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—psoriasis	1.89e-05	0.000211	CcSEcCtD
Ketoprofen—Headache—Methotrexate—psoriasis	1.88e-05	0.00021	CcSEcCtD
Ketoprofen—PTGS2—Metabolism—CYP2S1—psoriasis	1.85e-05	0.000583	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—APOE—psoriasis	1.82e-05	0.000576	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—LEP—psoriasis	1.82e-05	0.000576	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—psoriasis	1.79e-05	0.000565	CbGpPWpGaD
Ketoprofen—Nausea—Methotrexate—psoriasis	1.78e-05	0.000199	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—NOS2—psoriasis	1.77e-05	0.00056	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NDUFA5—psoriasis	1.77e-05	0.000558	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NDUFA5—psoriasis	1.76e-05	0.000555	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NFKBIA—psoriasis	1.7e-05	0.000537	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—psoriasis	1.66e-05	0.000526	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.65e-05	0.000521	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.64e-05	0.000518	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL6—psoriasis	1.64e-05	0.000517	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.63e-05	0.000516	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.61e-05	0.000509	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	1.61e-05	0.000508	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.6e-05	0.000506	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TNF—psoriasis	1.57e-05	0.000498	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.56e-05	0.000492	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—IL6—psoriasis	1.52e-05	0.000482	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP2S1—psoriasis	1.5e-05	0.000475	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP2S1—psoriasis	1.49e-05	0.000472	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CARM1—psoriasis	1.49e-05	0.000472	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NDUFA5—psoriasis	1.44e-05	0.000454	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.43e-05	0.000452	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.39e-05	0.000441	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TYK2—psoriasis	1.39e-05	0.00044	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—psoriasis	1.39e-05	0.000439	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.38e-05	0.000435	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.34e-05	0.000424	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.3e-05	0.000411	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL6—psoriasis	1.27e-05	0.000402	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.25e-05	0.000395	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP2S1—psoriasis	1.22e-05	0.000386	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000385	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCL8—psoriasis	1.21e-05	0.000383	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL6—psoriasis	1.15e-05	0.000364	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CARM1—psoriasis	1.14e-05	0.000359	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—JUN—psoriasis	1.13e-05	0.000356	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SOCS1—psoriasis	1.11e-05	0.000352	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NFKB1—psoriasis	1.08e-05	0.000342	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.07e-05	0.000339	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—TYK2—psoriasis	1.06e-05	0.000336	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000335	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—psoriasis	1.03e-05	0.000324	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—psoriasis	9.83e-06	0.000311	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—STAT3—psoriasis	9.73e-06	0.000308	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.67e-06	0.000306	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.44e-06	0.000299	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CAT—psoriasis	9.18e-06	0.00029	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CARM1—psoriasis	9.01e-06	0.000285	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	9e-06	0.000284	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.42e-06	0.000266	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—LEP—psoriasis	8.22e-06	0.00026	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APOE—psoriasis	8.22e-06	0.00026	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—psoriasis	8.01e-06	0.000253	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.87e-06	0.000249	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.82e-06	0.000247	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—psoriasis	7.75e-06	0.000245	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NFKBIA—psoriasis	7.66e-06	0.000242	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—psoriasis	7.43e-06	0.000235	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CARM1—psoriasis	7.33e-06	0.000232	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CARM1—psoriasis	7.29e-06	0.000231	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—APOE—psoriasis	7.13e-06	0.000225	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CAT—psoriasis	6.98e-06	0.000221	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.85e-06	0.000217	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.81e-06	0.000215	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—psoriasis	6.8e-06	0.000215	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.4e-06	0.000202	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TYK2—psoriasis	6.27e-06	0.000198	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—psoriasis	6.21e-06	0.000196	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CARM1—psoriasis	5.97e-06	0.000189	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.58e-06	0.000176	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CAT—psoriasis	5.54e-06	0.000175	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HLA-A—psoriasis	5.51e-06	0.000174	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOE—psoriasis	5.43e-06	0.000172	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—psoriasis	5.19e-06	0.000164	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOE—psoriasis	5.14e-06	0.000163	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—JUN—psoriasis	5.08e-06	0.000161	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NFKB1—psoriasis	4.89e-06	0.000155	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—psoriasis	4.79e-06	0.000152	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—psoriasis	4.73e-06	0.000149	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—psoriasis	4.64e-06	0.000147	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CAT—psoriasis	4.51e-06	0.000143	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CAT—psoriasis	4.48e-06	0.000142	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—psoriasis	4.44e-06	0.00014	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—psoriasis	4.39e-06	0.000139	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOE—psoriasis	4.31e-06	0.000136	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TYK2—psoriasis	3.93e-06	0.000124	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—psoriasis	3.75e-06	0.000119	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CAT—psoriasis	3.67e-06	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD4—psoriasis	3.55e-06	0.000112	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—psoriasis	3.5e-06	0.000111	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOE—psoriasis	3.5e-06	0.000111	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOE—psoriasis	3.48e-06	0.00011	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—psoriasis	3.35e-06	0.000106	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—psoriasis	3.07e-06	9.7e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—psoriasis	3.05e-06	9.65e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—psoriasis	3.03e-06	9.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOE—psoriasis	2.85e-06	9.02e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—psoriasis	2.75e-06	8.69e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—psoriasis	2.48e-06	7.85e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—psoriasis	1.92e-06	6.07e-05	CbGpPWpGaD
